Neurology Advisor: Infective endocarditis-related stroke more associated with IV drug use
Between 20% and 40% of patients with infective endocarditis, or inflammation of the inner lining and valves of the heart, will have an ischemic stroke event.
Researchers at the University of Cincinnati recently published findings in Neurology that found rates of infective endocarditis-related stroke (IERS) in the U.S. increased from 2005-2015, with affected patients more likely to be intravenous (IV) drug users.
Over time, more patients with IERS were IV drug users and fewer had hypertension. Patients who were drug users were also younger and fewer were women.
Rates of IERS increased from 1.31 per 100,000 in 2005 to 1.66 per 100,000 in 2010 and 2.41 per 100,000 in 2015. Rates of non-endocarditis stroke decreased slightly from 280 per 100,000 in 2005 to 274 per 100,000 in 2015.
“The impact of the opioid epidemic is reflected in the transforming phenotype of IERS," the researchers wrote.
Read the Neurology Advisor article.
Featured photo at top of brain courtesy of iStock.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.